Legislation co-authored by State Representative Ryan Lauer aimed at establishing new grant programs for pediatric and breast cancer research has been passed by the Indiana legislature. The bill, known as House Enrolled Act 1453, is now set to be reviewed by the governor.
The proposed act focuses on two grant initiatives: the Pediatric Cancer Research and Treatment Grant Program and the Breast Cancer Research Fund. The objective is to provide financial support for innovative research exploring new treatment options. Lauer emphasized Indiana’s potential role in advancing cancer treatment, stating, “As medicine and technology continue to advance, Indiana can be on the cutting edge of innovative treatments to help prevent and treat cancer.”
Statistical data shared by the Indiana Department of Health highlights the prevalence of pediatric cancer in the state. Between 2016 and 2020, more than 300 new cases were reported annually among children aged 0 to 19. In the same period, over 30 Indiana children died each year from cancer. Nationally, the American Cancer Society projects that over 9,000 U.S. children will be diagnosed with cancer in 2025, with the disease remaining the second leading cause of death for children aged 1 to 14.
Lauer expressed his hope that through increased funding, Indiana could develop novel therapies benefitting not just the state but potentially leading to treatments adopted nationwide.
House Enrolled Act 1453 was passed unanimously by the Indiana General Assembly and now awaits the governor’s approval.
Further details about the bill can be found at iga.in.gov.
